Hepatic alect-2 amyloidosis causing portal hypertension and recurrent variceal bleeding

17Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Objectives: To examine laser microdissection and mass spectrometry (LMD-MS), which has emerged as a new tool to aid in typing amyloid proteins. Results: ALECT-2 is a potential cause of hepatic amyloidosis best detected by LMD-MS. Methods: One of the more recently reported proteins is ALECT-2 (leukocyte cell-derived chemotaxin 2) amyloid, found in renal specimens of Hispanic patients. Here we report the first case of hepatic ALECT-2 amyloidosis diagnosed by LMD-MS from a liver biopsy specimen of a 52 year-old Hispanic man and causing portal hypertension with recurrent esophageal variceal bleeding. Conclusions: ALECT-2 can cause amyloidosis in organs other than the kidneys. It should be strongly considered in Hispanic patients and in those with a globular pattern of amyloid deposition. The incidence of ALECT-2 amyloidosis is likely underreported.

Cite

CITATION STYLE

APA

Damlaj, M., Amre, R., Wong, P., & How, J. (2014). Hepatic alect-2 amyloidosis causing portal hypertension and recurrent variceal bleeding. American Journal of Clinical Pathology, 141(2), 288–291. https://doi.org/10.1309/AJCPCLK54RKXTRDI

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free